2.0
30 Mar 2021
Current employee, more than 10 years
London, England
Recommend
CEO approval
Business outlook
Pros
Excellent colleagues / scientists, great collaborations via matrix teams and via external partnerships to boost drug discovery
Cons
Change in culture/values, very poor senior leadership (CEO and LT), clunky over-complex systems, lack of agility